Compositions and methods of use for modified release minoxidil
AssigneeVeradermics Incorporated
InventorReid WALDMAN
Life of this patent
Estimating the term…
Loading patent…
AssigneeVeradermics Incorporated
InventorReid WALDMAN
Estimating the term…
The compositions and methods provided herein include a pharmaceutical formulation for oral administration comprising a daily dose of a modified release formulation of minoxidil or a pharmaceutically acceptable salt thereof. Also provided herein are pharmaceutical formulations for oral administration comprising a daily dose of a modified release formulation of minoxidil or a pharmaceutically acceptable salt thereof and one or more additional active agents. Also provided herein are methods of treating hair loss by administering to a subject in need thereof a daily dose of a modified release formulation of minoxidil or a pharmaceutically acceptable salt thereof. Further provided herein is a kit including a slow modified release vehicle comprising oral minoxidil or a pharmaceutically acceptable salt thereof.
An oral dosage form comprising about 4 mg to about 6 mg of minoxidil, or a molar equivalent amount of a pharmaceutically acceptable salt thereof, and a natural oil, a mineral oil, a fatty acid ester, a wax, or a combination thereof.
An oral dosage form comprising about 4 mg to about 6 mg of minoxidil, or a molar equivalent amount of a pharmaceutically acceptable salt thereof, wherein the oral dosage form is configured to provide extended release, wherein the oral dosage form has the property that about 25% of the total amount of minoxidil, or the pharmaceutically acceptable salt thereof, in the dosage form is released from about 0 hours to about 2 hours at a pH of 6.8.
An oral dosage form comprising about 1 mg to about 1.5 mg of minoxidil, or a molar equivalent amount of a pharmaceutically acceptable salt thereof, and a natural oil, a mineral oil, a fatty acid ester, a wax, or a combination thereof.
Dependencies are inferred from the claim text.